World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
43420
World Ranking
4596
National Ranking
2496

Robert L. Findling publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert L. Findling sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 702 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert L. Findling D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert L. Findling sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Robert L. Findling is affiliated with Virginia Commonwealth University in the United States. Their research spans a range of topics primarily within Medicine and Psychology, with a significant focus on Psychiatry and Mental Health, Clinical Psychology, Speech and Hearing, Cognitive Neuroscience, and Pediatrics, Perinatology, and Child Health.

Their work addresses multiple main topics, including:

  • Child and Adolescent Psychosocial and Emotional Development
  • Bipolar Disorder and Treatment
  • Attention Deficit Hyperactivity Disorder
  • Adolescent and Pediatric Healthcare
  • Autism Spectrum Disorder Research
  • Pharmaceutical studies and practices
  • Child Nutrition and Feeding Issues

Recent notable research publications authored or co-authored by Findling include:

  • "A novel digital intervention for actively reducing severity of paediatric ADHD (STARS-ADHD): a randomised controlled trial" (2020), published in The Lancet Digital Health
  • "Practice guideline: Treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder" (2020), published in Neurology
  • "Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder" (2020), published in the Journal of the American Academy of Child & Adolescent Psychiatry
  • "A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children" (2020), published in Clinical Therapeutics
  • "Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial" (2021), published in Clinical Therapeutics

Frequent co-authors collaborating with Findling include:

  • Eric A. Youngstrom
  • Mary A. Fristad
  • Boris Birmaher
  • Sarah McCue Horwitz
  • Thomas Frazier

Findling's publications are predominantly featured in venues such as:

  • UNC Libraries
  • Journal of the American Academy of Child & Adolescent Psychiatry
  • JAACAP Open
  • Journal of Child and Adolescent Psychopharmacology
  • CNS Spectrums

Their research outputs reflect strong contributions to child and adolescent psychiatry and psychopharmacology, with considerable work on developmental and treatment-related aspects of psychiatric disorders in pediatric populations.

Best Publications

  • Rare Structural Variants Disrupt Multiple Genes in Neurodevelopmental Pathways in Schizophrenia

    Tom Walsh;Jon M. McClellan;Shane E. McCarthy;Anjené M. Addington

  • A fluid percussion model of experimental brain injury in the rat

    C. E. Dixon;Bruce G Lyeth;J. T. Povlishock;R. L. Findling

  • The Treatment for Adolescents with Depression Study (TADS): Long-term effectiveness and safety outcomes

    John S. March;Susan Silva;Stephen Petrycki;John Curry

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Treatment guidelines for children and adolescents with bipolar disorder

    Robert A Kowatch;Mary Fristad;Boris Birmaher;Karen Dineen Wagner

  • Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.

    Randall Owen;Linmarie Sikich;Ronald N. Marcus;Patricia Corey-Lisle

  • Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study

    Linmarie Sikich;Jean A. Frazier;Jon McClellan;Robert L. Findling

  • Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence

    Michael G. Aman;Goedele De Smedt;Albert Derivan;Ben Lyons

  • Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

    Jon McClellan;Robert Kowatch;Robert L. Findling

  • Validation of Proposed DSM-5 Criteria for Autism Spectrum Disorder

    Thomas W. Frazier;Eric Arden Youngstrom;Leslie Speer;Rebecca Embacher

  • Review and meta‐analysis of the phenomenology and clinical characteristics of mania in children and adolescents

    Robert A Kowatch;Eric A Youngstrom;Arman Danielyan;Robert L Findling

  • Rapid, continuous cycling and psychiatric co‐morbidity in pediatric bipolar I disorder

    Robert L Findling;Barbara L Gracious;Nora K McNamara;Eric A Youngstrom

  • International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions.

    Stan Kutcher;Michael Aman;Sarah J Brooks;Jan Buitelaar

  • A Randomized, Placebo-Controlled Trial of Citalopram for the Treatment of Major Depression in Children and Adolescents

    Karen Dineen Wagner;Adelaide S. Robb;Robert L. Findling;Jianqing Jin

  • A double-blind pilot study of risperidone in the treatment of conduct disorder.

    Robert L. Findling;Nora K. McNAMARA;Lisa A. Branicky;Mark D. Schluchter

  • Olanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania

    Mauricio Tohen;Ludmila Kryzhanovskaya;Gabrielle Carlson;Melissa DelBello

  • A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia.

    Robert L. Findling;Adelaide Robb;Margaretta Nyilas;Robert A. Forbes

  • Treatment Recommendations for the Use of Antipsychotics for Aggressive Youth (TRAAY). Part II

    Elizabeth Pappadopulos;James C. Macintyre Ii;M. Lynn Crismon;Robert L. Findling

  • Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.

    Joseph Biederman;Suma Krishnan;Yuxin Zhang;James J. McGough

  • Treatment Guidelines for Children and Adolescents With Bipolar Disorder: Child Psychiatric Workgroup on Bipolar Disorder

    Robert A. Kowatch;Mary Fristad;Boris Birmaher;Karen Dineen Wagner

Frequent Co-Authors

Eric A. Youngstrom
Eric A. Youngstrom University of North Carolina at Chapel Hill
Joseph R. Calabrese
Joseph R. Calabrese Case Western Reserve University
L. Eugene Arnold
L. Eugene Arnold The Ohio State University
Mary A. Fristad
Mary A. Fristad The Ohio State University
Boris Birmaher
Boris Birmaher University of Pittsburgh
Sarah M. Horwitz
Sarah M. Horwitz New York University
Thomas W. Frazier
Thomas W. Frazier John Carroll University
David Axelson
David Axelson The Ohio State University
Norah C. Feeny
Norah C. Feeny Case Western Reserve University
Michael G. Aman
Michael G. Aman The Ohio State University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your healthcare career options beyond medical school? There are several flexible, accredited online degree pathways designed for current and aspiring healthcare professionals. For those seeking leadership roles in healthcare settings, the healthcare administration accelerated degree is a popular choice, allowing you to fast-track your career in hospital or clinic management.

If you are an RN looking to advance to a nurse practitioner role, consider enrolling in an rn to np bridge program. These programs are designed to build on your nursing experience and help you qualify for higher-paying, more autonomous positions.

Nutrition science is also a growing field with strong online options. Earning an online bachelor's in nutrition can open doors in wellness coaching, community health, and dietetics.

For those aiming for senior leadership roles, many professionals opt for cahme accredited online mha programs. These accredited master's programs meet high educational standards and prepare students for executive positions in healthcare organizations.

Best Scientists Citing Robert L. Findling

Trending Scientists

Recently Published Articles